Annual Net Income
-$135.89 M
-$73.80 M-118.86%
31 December 2023
Summary:
Tarsus Pharmaceuticals annual net profit is currently -$135.89 million, with the most recent change of -$73.80 million (-118.86%) on 31 December 2023. During the last 3 years, it has fallen by -$109.08 million (-406.86%). TARS annual net income is now -10202.73% below its all-time high of -$1.32 million, reached on 31 December 2018.TARS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$23.42 M
+$9.87 M+29.65%
30 September 2024
Summary:
Tarsus Pharmaceuticals quarterly net profit is currently -$23.42 million, with the most recent change of +$9.87 million (+29.65%) on 30 September 2024. Over the past year, it has increased by +$15.73 million (+40.18%). TARS quarterly net income is now -325.71% below its all-time high of $10.38 million, reached on 31 March 2021.TARS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$134.34 M
+$15.73 M+10.48%
30 September 2024
Summary:
Tarsus Pharmaceuticals TTM net profit is currently -$134.34 million, with the most recent change of +$15.73 million (+10.48%) on 30 September 2024. Over the past year, it has dropped by -$26.75 million (-24.87%). TARS TTM net income is now -19627.31% below its all-time high of -$681.00 thousand, reached on 30 September 2019.TARS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARS Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -118.9% | +40.2% | -24.9% |
3 y3 years | -406.9% | -49.2% | -1186.4% |
5 y5 years | -10000.0% | -3339.1% | -10000.0% |
TARS Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -882.8% | at low | -307.8% | +44.1% | -1186.4% | +10.5% |
5 y | 5 years | <-9999.0% | at low | -325.7% | +44.1% | <-9999.0% | +10.5% |
alltime | all time | <-9999.0% | at low | -325.7% | +44.1% | <-9999.0% | +10.5% |
Tarsus Pharmaceuticals Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$23.42 M(-29.6%) | -$134.34 M(-10.5%) |
June 2024 | - | -$33.29 M(-6.8%) | -$150.07 M(+1.3%) |
Mar 2024 | - | -$35.73 M(-14.7%) | -$148.21 M(+9.1%) |
Dec 2023 | -$135.89 M(+118.9%) | -$41.90 M(+7.0%) | -$135.89 M(+26.3%) |
Sept 2023 | - | -$39.15 M(+24.6%) | -$107.59 M(+18.3%) |
June 2023 | - | -$31.42 M(+34.2%) | -$90.95 M(+39.3%) |
Mar 2023 | - | -$23.42 M(+72.2%) | -$65.27 M(+5.1%) |
Dec 2022 | -$62.09 M(+349.1%) | -$13.60 M(-39.6%) | -$62.09 M(-2.0%) |
Sept 2022 | - | -$22.51 M(+292.0%) | -$63.34 M(+12.1%) |
June 2022 | - | -$5.74 M(-71.6%) | -$56.53 M(+27.2%) |
Mar 2022 | - | -$20.24 M(+36.3%) | -$44.44 M(+221.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$13.83 M(-48.4%) | -$14.85 M(-5.4%) | -$13.83 M(+32.4%) |
Sept 2021 | - | -$15.70 M(-347.4%) | -$10.44 M(+113.8%) |
June 2021 | - | $6.34 M(-38.8%) | -$4.88 M(-66.3%) |
Mar 2021 | - | $10.38 M(-190.5%) | -$14.48 M(-46.0%) |
Dec 2020 | -$26.81 M(+474.1%) | -$11.47 M(+13.1%) | -$26.81 M(+60.0%) |
Sept 2020 | - | -$10.14 M(+211.9%) | -$16.76 M(+129.5%) |
June 2020 | - | -$3.25 M(+66.1%) | -$7.30 M(+80.2%) |
Mar 2020 | - | -$1.96 M(+38.6%) | -$4.05 M(+93.5%) |
Dec 2019 | -$4.67 M(+254.1%) | -$1.41 M(+107.3%) | -$2.09 M(+207.3%) |
Sept 2019 | - | -$681.00 K | -$681.00 K |
Dec 2018 | -$1.32 M | - | - |
FAQ
- What is Tarsus Pharmaceuticals annual net profit?
- What is the all time high annual net income for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual net income year-on-year change?
- What is Tarsus Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly net income year-on-year change?
- What is Tarsus Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals TTM net income year-on-year change?
What is Tarsus Pharmaceuticals annual net profit?
The current annual net income of TARS is -$135.89 M
What is the all time high annual net income for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual net profit is -$1.32 M
What is Tarsus Pharmaceuticals annual net income year-on-year change?
Over the past year, TARS annual net profit has changed by -$73.80 M (-118.86%)
What is Tarsus Pharmaceuticals quarterly net profit?
The current quarterly net income of TARS is -$23.42 M
What is the all time high quarterly net income for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly net profit is $10.38 M
What is Tarsus Pharmaceuticals quarterly net income year-on-year change?
Over the past year, TARS quarterly net profit has changed by +$15.73 M (+40.18%)
What is Tarsus Pharmaceuticals TTM net profit?
The current TTM net income of TARS is -$134.34 M
What is the all time high TTM net income for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high TTM net profit is -$681.00 K
What is Tarsus Pharmaceuticals TTM net income year-on-year change?
Over the past year, TARS TTM net profit has changed by -$26.75 M (-24.87%)